摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,9,15,21-Tetratert-butyl-26,26,28,28-tetra(propan-2-yl)-25,27,29-trioxa-6,12,18,31-tetrathia-26,28-disilahexacyclo[21.7.1.17,11.113,17.05,30.019,24]tritriaconta-1,3,5(30),7,9,11(33),13(32),14,16,19(24),20,22-dodecaene-32,33-diol | 430452-13-4

中文名称
——
中文别名
——
英文名称
3,9,15,21-Tetratert-butyl-26,26,28,28-tetra(propan-2-yl)-25,27,29-trioxa-6,12,18,31-tetrathia-26,28-disilahexacyclo[21.7.1.17,11.113,17.05,30.019,24]tritriaconta-1,3,5(30),7,9,11(33),13(32),14,16,19(24),20,22-dodecaene-32,33-diol
英文别名
——
3,9,15,21-Tetratert-butyl-26,26,28,28-tetra(propan-2-yl)-25,27,29-trioxa-6,12,18,31-tetrathia-26,28-disilahexacyclo[21.7.1.17,11.113,17.05,30.019,24]tritriaconta-1,3,5(30),7,9,11(33),13(32),14,16,19(24),20,22-dodecaene-32,33-diol化学式
CAS
430452-13-4;699001-14-4
化学式
C52H74O5S4Si2
mdl
——
分子量
963.592
InChiKey
RGKLXGYJXDSSFJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    17.52
  • 重原子数:
    63
  • 可旋转键数:
    8
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    169
  • 氢给体数:
    2
  • 氢受体数:
    9

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • First synthesis of 25,26-bridged thiacalix[4]crowns by the use of a 25,26-O-disiloxanediyl-capped p-tert-butylthiacalix[4]arene
    作者:Fumitaka Narumi、Nobuji Matsumura、Naoya Morohashi、Hiroshi Kameyama、Sotaro Miyano
    DOI:10.1039/b206050g
    日期:2002.8.8
    The first and facile synthesis of 25,26-bridged thiacalix[4]crowns (2a–f) is disclosed by treatment of readily available 25,26-O-tetraisopropyldisiloxanediyl-capped p-tert-butylthiacalix[4]arene (3) with difunctional alkylating agents (5a–f) and subsequent desilylation.
    通过用以下物质处理容易获得的 25,26-O-四异丙基二硅氧烷二基封端的对叔丁基 thiacalix[4] 芳烃 (3),首次简便地合成了 25,26-桥联 thiacalix[4] 冠 (2a-f)。双官能烷基化剂 (5a–f) 和随后的脱甲硅烷基化。
  • Proximal O,O′-capped calix[4]arenes with a disiloxane bridge as highly efficient synthetic intermediates for 1,2-dialkylation at the lower rim
    作者:Fumitaka Narumi、Naoya Morohashi、Nobuji Matsumura、Nobuhiko Iki、Hiroshi Kameyama、Sotaro Miyano
    DOI:10.1016/s0040-4039(01)02202-x
    日期:2002.1
    Treatment of calix[4]arenes with 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane using imidazole as a base yielded O,O′-bridged calixarenes in excellent yields, which were subsequently treated with an alkyl halide/base to give O″,O‴-dialkylated products in high yields. These were, in turn, amenable to fluoride-promoted quantitative desilylation, thus providing an efficient method for the net proximal
    杯的治疗[4]使用咪唑作为碱,得到1,3-二氯- 1,1,3,3-四异丙基芳烃Ö,ö '-bridged杯芳烃以优良产率,其随后用烷基卤处理/碱为了让Ø “ Ø '''二烷基化产品的高收益。这些反过来又适合氟化物促进的定量脱甲硅烷基化,因此为下边缘杯[4]芳烃的净近端二烷基化提供了一种有效的方法。
  • Stereoselective dialkylation of the proximal hydroxy groups of calix- and thiacalix[4]arenes
    作者:Fumitaka Narumi、Tetsutaro Hattori、Naoya Morohashi、Nobuji Matsumura、Waka Yamabuki、Hiroshi Kameyama、Sotaro Miyano
    DOI:10.1039/b315867e
    日期:——
    Treatment of p-tert-butylcalix[4]arene (C1) and its sulfur-bridged analog T1 with 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane in the presence of imidazole gives proximally O,O'-disiloxane-1,3-diyl-bridged calixarenes C2 and T2 in excellent yields, respectively. Subsequent base-catalyzed etherification of the remaining hydroxy groups with alkyl halides gives syn- and anti-O'',O'''-dialkylated products
    在咪唑存在下,用1,3-二氯-1,1,3,3-四异丙基二硅氧烷处理对叔丁基杯[4]芳烃(C1)及其硫桥键类似物T1,得到近端的O,O'-二硅氧烷-1,3-二基桥接杯芳烃C2和T2分别具有出色的收率。随后,其余的羟基与烷基卤进行碱催化的醚化反应,生成顺-和反-O'',O'''-二烷基化产物,其立体选择性取决于大环化合物以及金属阳离子的性质所使用的基础。因此,传统的杯芳烃C2借助叔丁醇钾和K(2)CO(3)优先提供1,2-交替构象(C3)的合成化合物,以及具有Cs(2)的部分圆锥构象(C4)的反对应物)CO(3)。另一方面,硫杂杯芳烃T2可提供1的合成化合物 具有任何碱基的2-交替构象(T3)。通过用四丁基氟化铵处理,可以容易地除去所得产物的二硅氧烷二基桥。因此,净工艺为近端二烷基化杯[4]芳烃的区域和立体选择性合成提供了一种有效的方法。
  • Stereoselective synthesis of all stereoisomers of vicinal and distal bis(O-2-aminoethyl)-p-tert-butylthiacalix[4]arene
    作者:Vandana Bhalla、Manoj Kumar、Tetsutaro Hattori、Sotaro Miyano
    DOI:10.1016/j.tet.2004.05.035
    日期:2004.7
    O,O"- and O,O'-bis(2-aminoethyl)-p-tert-butylthiacalix[4]arenes of anti conformation have been prepared by the reduction of the corresponding O,O"- and O,O'-bis(cyanomethyl) ethers. Their syn-O,O"- and O,O'-counterparts have been prepared by alternative routes via the Mitsunobu reaction of thiacalix[4]arene with N-(2-hydroxyethyl)phthalimide and the reduction of a O,O'-disiloxanediyl-bridged O",O"'-bis(cyanomethyl) ether of 1,2-alternate conformation, respectively. These products are expected to serve as useful precursors of highly elaborated synthetic receptors, including biscalixarenes. (C) 2004 Elsevier Ltd. All rights reserved.
  • Synthesis of an inherently chiral O,O′-bridged thiacalix[4]crowncarboxylic acid and its application to a chiral solvating agent
    作者:Fumitaka Narumi、Tetsutaro Hattori、Nobuji Matsumura、Toru Onodera、Hiroshi Katagiri、Chizuko Kabuto、Hiroshi Kameyama、Sotaro Miyano
    DOI:10.1016/j.tet.2004.06.074
    日期:2004.8
    Treatment of readily available O,O'-1,1,3,3-tetraisopropyldisiloxane-1,3-diyl-bridged p-tert-butylthiacalix[4]arene (1) with tri(ethylene glycol) di-p-tosylate and subsequent desilylation gave O,O'-bridged thiacalix [4] crown 3 in an excellent yield. Mono-O-alkylation of 3 with ethyl bromoacetate, followed by optical resolution by chiral HPLC, and subsequent hydrolysis of the ester moiety gave inherently chiral O,O'-bridged thiacalix[4]crowncarboxylic acid (+)-6, which clearly discriminated enantiomeric primary amines, as well as amino esters, by H-1 NMR spectroscopy. (C) 2004 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

2,9-二(2-苯乙基)蒽并[2,1,9-DEF:6,5,10-D’E’F’]二异喹啉-1,3,8,10(2H,9H)-四酮 (βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-盐酸沙丁胺醇 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-3,3''-双([[1,1''-联苯]-4-基)-[1,1''-联萘]-2,2''-二醇 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,5R)-3,3a,8,8a-四氢茚并[1,2-d]-1,2,3-氧杂噻唑-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aS,8aR)-2-(吡啶-2-基)-8,8a-二氢-3aH-茚并[1,2-d]恶唑 (3aS,3''aS,8aR,8''aR)-2,2''-环戊二烯双[3a,8a-二氢-8H-茚并[1,2-d]恶唑] (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3S,3aR)-2-(3-氯-4-氰基苯基)-3-环戊基-3,3a,4,5-四氢-2H-苯并[g]吲唑-7-羧酸 (3R,3’’R,4S,4’’S,11bS,11’’bS)-(+)-4,4’’-二叔丁基-4,4’’,5,5’’-四氢-3,3’’-联-3H-二萘酚[2,1-c:1’’,2’’-e]膦(S)-BINAPINE (3-三苯基甲氨基甲基)吡啶 (3-[(E)-1-氰基-2-乙氧基-2-hydroxyethenyl]-1-氧代-1H-茚-2-甲酰胺) (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,4S)-Fmoc-4-三氟甲基吡咯烷-2-羧酸 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-硝基苯基)磷酸三酰胺 (2-氯-6-羟基苯基)硼酸 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1α,1'R,4β)-4-甲氧基-5''-甲基-6'-[5-(1-丙炔基-1)-3-吡啶基]双螺[环己烷-1,2'-[2H]indene (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1R,1′R,2S,2′S)-2,2′-二叔丁基-2,3,2′,3′-四氢-1H,1′H-(1,1′)二异磷哚